These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9823325

  • 1. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene.
    Hogan KT, Eisinger DP, Cupp SB, Lekstrom KJ, Deacon DD, Shabanowitz J, Hunt DF, Engelhard VH, Slingluff CL, Ross MM.
    Cancer Res; 1998 Nov 15; 58(22):5144-50. PubMed ID: 9823325
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68.
    Slingluff CL, Cox AL, Stover JM, Moore MM, Hunt DF, Engelhard VH.
    Cancer Res; 1994 May 15; 54(10):2731-7. PubMed ID: 7513255
    [Abstract] [Full Text] [Related]

  • 3. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
    Seki N, Hoshino T, Kikuchi M, Hayashi A, Itoh K.
    Cell Immunol; 1997 Feb 01; 175(2):101-10. PubMed ID: 9023415
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival.
    Karanikas V, Colau D, Baurain JF, Chiari R, Thonnard J, Gutierrez-Roelens I, Goffinet C, Van Schaftingen EV, Weynants P, Boon T, Coulie PG.
    Cancer Res; 2001 May 01; 61(9):3718-24. PubMed ID: 11325844
    [Abstract] [Full Text] [Related]

  • 6. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
    Kobayashi J, Hirohashi Y, Torigoe T, Michifuri Y, Yamamoto T, Tamura Y, Kamiguchi K, Miyazaki A, Yamaguchi A, Hariu H, Hiratsuka H, Sato N.
    Hum Immunol; 2009 Feb 01; 70(2):89-95. PubMed ID: 19124056
    [Abstract] [Full Text] [Related]

  • 7. A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma.
    Nishizaka S, Gomi S, Harada K, Oizumi K, Itoh K, Shichijo S.
    Cancer Res; 2000 Sep 01; 60(17):4830-7. PubMed ID: 10987294
    [Abstract] [Full Text] [Related]

  • 8. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs.
    Gomi S, Nakao M, Niiya F, Imamura Y, Kawano K, Nishizaka S, Hayashi A, Sobao Y, Oizumi K, Itoh K.
    J Immunol; 1999 Nov 01; 163(9):4994-5004. PubMed ID: 10528204
    [Abstract] [Full Text] [Related]

  • 9. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.
    Fukuyama T, Hanagiri T, Takenoyama M, Ichiki Y, Mizukami M, So T, Sugaya M, So T, Sugio K, Yasumoto K.
    Cancer Res; 2006 May 01; 66(9):4922-8. PubMed ID: 16651449
    [Abstract] [Full Text] [Related]

  • 10. HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma.
    Nakao M, Yamana H, Imai Y, Toh Y, Toh U, Kimura A, Yanoma S, Kakegawa T, Itoh K.
    Cancer Res; 1995 Oct 01; 55(19):4248-52. PubMed ID: 7671230
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct 01; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

  • 13. Identification of squamous cell carcinoma antigen-derived peptides having the capacity of inducing cancer-reactive CTLs in HLA-A24+ cancer patients.
    Homma S, Harada M, Yano H, Ogasawara S, Shichijo S, Matsueda S, Komatsu N, Shomura H, Maeda Y, Sato Y, Todo S, Itoh K.
    Int J Oncol; 2006 Sep 01; 29(3):577-87. PubMed ID: 16865273
    [Abstract] [Full Text] [Related]

  • 14. Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient.
    Nagata Y, Hanagiri T, Takenoyama M, Fukuyama T, Mizukami M, So T, Ichiki Y, Sugaya M, Sugio K, Yasumoto K.
    Clin Cancer Res; 2005 Jul 15; 11(14):5265-72. PubMed ID: 16033845
    [Abstract] [Full Text] [Related]

  • 15. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes in an HLA-A24 restricted manner.
    Kontani K, Teramoto K, Ozaki Y, Fujita T, Tezuka N, Sawai S, Watanabe H, Fujino S, Yokomise H, Ohkubo I.
    Int J Oncol; 2004 Dec 15; 25(6):1537-42. PubMed ID: 15547688
    [Abstract] [Full Text] [Related]

  • 16. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K, Spruill G, Rhoderick J, Spielman J, Savaraj N, Podack ER.
    Cancer Res; 1999 Sep 15; 59(18):4642-50. PubMed ID: 10493519
    [Abstract] [Full Text] [Related]

  • 17. Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.
    Shichijo S, Azuma K, Komatsu N, Ito M, Maeda Y, Ishihara Y, Itoh K.
    Clin Cancer Res; 2004 Sep 01; 10(17):5828-36. PubMed ID: 15355913
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gene and peptide analyses of newly defined lung cancer antigens recognized by HLA-A2402-restricted tumor-specific cytotoxic T lymphocytes.
    Yamada A, Kawano K, Koga M, Takamori S, Nakagawa M, Itoh K.
    Cancer Res; 2003 Jun 01; 63(11):2829-35. PubMed ID: 12782588
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.